129 related articles for article (PubMed ID: 9919110)
1. The prevalence and detection of psychiatric morbidity in patients with metastatic breast cancer.
Fulton C
Eur J Cancer Care (Engl); 1998 Dec; 7(4):232-9. PubMed ID: 9919110
[TBL] [Abstract][Full Text] [Related]
2. Patients with metastatic breast cancer: their physical and psychological rehabilitation needs.
Fulton C
Int J Rehabil Res; 1999 Dec; 22(4):291-301. PubMed ID: 10669979
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal effects of high-dose chemotherapy and autologous stem cell transplantation on quality of life in the treatment of metastatic breast cancer.
Carlson LE; Koski T; Glück S
Bone Marrow Transplant; 2001 May; 27(9):989-98. PubMed ID: 11436111
[TBL] [Abstract][Full Text] [Related]
4. Anxiety and depression symptoms in the 2 years following diagnosis of breast or gynaecologic cancer: prevalence, course and determinants of outcome.
Stafford L; Judd F; Gibson P; Komiti A; Mann GB; Quinn M
Support Care Cancer; 2015 Aug; 23(8):2215-24. PubMed ID: 25559036
[TBL] [Abstract][Full Text] [Related]
5. Anxiety and depression in breast cancer patients before and after participation in a cancer support group.
Montazeri A; Jarvandi S; Haghighat S; Vahdani M; Sajadian A; Ebrahimi M; Haji-Mahmoodi M
Patient Educ Couns; 2001 Dec; 45(3):195-8. PubMed ID: 11722855
[TBL] [Abstract][Full Text] [Related]
6. Predictors of depression and anxiety symptom trajectories in the 24 months following diagnosis of breast or gynaecologic cancer.
Stafford L; Komiti A; Bousman C; Judd F; Gibson P; Mann GB; Quinn M
Breast; 2016 Apr; 26():100-5. PubMed ID: 27017248
[TBL] [Abstract][Full Text] [Related]
7. Anxiety and Depression in Young Women With Metastatic Breast Cancer: A Cross-Sectional Study.
Park EM; Gelber S; Rosenberg SM; Seah DSE; Schapira L; Come SE; Partridge AH
Psychosomatics; 2018; 59(3):251-258. PubMed ID: 29525523
[TBL] [Abstract][Full Text] [Related]
8. The suitability of the Hospital Anxiety and Depression Scale, Distress Thermometer and other instruments to screen for psychiatric disorders in both lung cancer patients and their partners.
Schellekens MPJ; van den Hurk DGM; Prins JB; Molema J; van der Drift MA; Speckens AEM
J Affect Disord; 2016 Oct; 203():176-183. PubMed ID: 27295374
[TBL] [Abstract][Full Text] [Related]
9. Screening for depression and anxiety in women with breast and gynaecologic cancer: course and prevalence of morbidity over 12 months.
Stafford L; Judd F; Gibson P; Komiti A; Mann GB; Quinn M
Psychooncology; 2013 Sep; 22(9):2071-8. PubMed ID: 23401315
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of screening instruments for depression and anxiety in breast cancer survivors.
Alexander S; Palmer C; Stone PC
Breast Cancer Res Treat; 2010 Jul; 122(2):573-8. PubMed ID: 19960243
[TBL] [Abstract][Full Text] [Related]
11. Anxiety and depression in sarcoma patients: emotional adjustment and its determinants in the different phases of disease.
Paredes T; Canavarro MC; Simões MR
Eur J Oncol Nurs; 2011 Feb; 15(1):73-9. PubMed ID: 20667777
[TBL] [Abstract][Full Text] [Related]
12. Psychological impact of breast cancer screening in Japan.
Kitano A; Yamauchi H; Hosaka T; Yagata H; Hosokawa K; Ohde S; Nakamura S; Takimoto M; Tsunoda H
Int J Clin Oncol; 2015 Dec; 20(6):1110-6. PubMed ID: 26007689
[TBL] [Abstract][Full Text] [Related]
13. Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer?
Hall A; A'Hern R; Fallowfield L
Eur J Cancer; 1999 Jan; 35(1):79-85. PubMed ID: 10211092
[TBL] [Abstract][Full Text] [Related]
14. A psychometric evaluation of the Chinese version of the Hospital Anxiety and Depression Scale in patients with coronary heart disease.
Wang W; Chair SY; Thompson DR; Twinn SF
J Clin Nurs; 2009 Sep; 18(17):2436-43. PubMed ID: 19694877
[TBL] [Abstract][Full Text] [Related]
15. Repeat testing on the Edinburgh Depression Scale and the HADS-A in pregnancy: differentiating between transient and enduring distress.
Matthey S; Ross-Hamid C
J Affect Disord; 2012 Dec; 141(2-3):213-21. PubMed ID: 22695259
[TBL] [Abstract][Full Text] [Related]
16. Fatigue, anxiety and depression overrule the role of oncological treatment in predicting self-reported health complaints in women with breast cancer compared to healthy controls.
Hagen KB; Aas T; Kvaløy JT; Eriksen HR; Søiland H; Lind R
Breast; 2016 Aug; 28():100-6. PubMed ID: 27262826
[TBL] [Abstract][Full Text] [Related]
17. Depression and anxiety symptoms following cancer diagnosis: a cross-sectional study.
Cardoso G; Graca J; Klut C; Trancas B; Papoila A
Psychol Health Med; 2016 Jul; 21(5):562-70. PubMed ID: 26683266
[TBL] [Abstract][Full Text] [Related]
18. Effects of depression and anxiety on mortality in a mixed cancer group: a longitudinal approach using standardised diagnostic interviews.
Chan CM; Wan Ahmad WA; Yusof MM; Ho GF; Krupat E
Psychooncology; 2015 Jun; 24(6):718-25. PubMed ID: 25345781
[TBL] [Abstract][Full Text] [Related]
19. What goes up does not always come down: patterns of distress, physical and psychosocial morbidity in people with cancer over a one year period.
Carlson LE; Waller A; Groff SL; Giese-Davis J; Bultz BD
Psychooncology; 2013 Jan; 22(1):168-76. PubMed ID: 21971977
[TBL] [Abstract][Full Text] [Related]
20. Depression in lung cancer patients: is the HADS an effective screening tool?
Castelli L; Binaschi L; Caldera P; Torta R
Support Care Cancer; 2009 Aug; 17(8):1129-32. PubMed ID: 19283412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
